RT Book, Section
A1 Steinhoff, Martin
A1 Buddenkotte, Jörg
A2 Kang, Sewon
A2 Amagai, Masayuki
A2 Bruckner, Anna L.
A2 Enk, Alexander H.
A2 Margolis, David J.
A2 McMichael, Amy J.
A2 Orringer, Jeffrey S.
SR Print(0)
ID 1161325424
T1 Rosacea
T2 Fitzpatrick's Dermatology, 9e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9780071837798
LK dermatology.mhmedical.com/content.aspx?aid=1161325424
RD 2024/04/20
AB AT-A-GLANCERosacea  is  a  common  facial  skin  disease  in  many  countries.Signs  and  symptoms  for  rosacea  include  flushing,  transient  erythema,  persistent  erythema,  telangiectasia,  papules,  pustules,  phymata,  edema,  pain,  stinging  or  burning,  and  (very  rarely)  pruritus.The  pathophysiology  of  rosacea  is  poorly  understood;  however,  a  genetic  predisposition  along  with  trigger  factors  activate  a  dysregulated  neurovascular,  innate  immune,  and  adaptive  immune  system.Taking  a  thorough  family  and  patient  history  and  performing  a  clinical  examination  are  crucial  to  diagnose  rosacea.All  clinical  features  have  to  be  considered  with  severity  scores  for  a  proper  treatment,  combined  with  assessing  patient’s  quality  of  life.Approved  topical  or  systemic  drugs  exist  for  various,  but  not  all,  features  of  rosacea  and  should  be  used  on  the  basis  of  pathophysiology  and  while  considering  efficacy  and  side  effect  profiles.Knowledge  about  the  beneficial  use  of  physical  therapies  and  their  limitations  is  important  for  best  medical  practice  in  patients  with  rosacea.Education  about  disease  progress,  general  skin  care,  cosmetic  usage  and  medication  effects  and  potential  adverse  events  is  mandatory;  teaching  of  proper  topical  use  guarantees  better  treatment  results.Education  to  prevent  exacerbating  “trigger  factors”  is  critical  for  successful  management  of  patients  with  rosacea.